Citigroup’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$78.8K Sell
80,054
-106,591
-57% -$105K ﹤0.01% 3805
2025
Q1
$269K Sell
186,645
-5,478
-3% -$7.89K ﹤0.01% 3266
2024
Q4
$423K Buy
192,123
+26,119
+16% +$57.5K ﹤0.01% 3134
2024
Q3
$274K Buy
166,004
+115,973
+232% +$191K ﹤0.01% 3375
2024
Q2
$111K Sell
50,031
-306,717
-86% -$681K ﹤0.01% 3439
2024
Q1
$956K Sell
356,748
-21,243
-6% -$56.9K ﹤0.01% 2402
2023
Q4
$1.13M Buy
377,991
+363,058
+2,431% +$1.09M ﹤0.01% 2061
2023
Q3
$14.6K Sell
14,933
-276
-2% -$270 ﹤0.01% 3761
2023
Q2
$21.1K Sell
15,209
-24,719
-62% -$34.4K ﹤0.01% 4261
2023
Q1
$63.5K Buy
39,928
+24,257
+155% +$38.6K ﹤0.01% 3557
2022
Q4
$97.6K Buy
15,671
+2,619
+20% +$16.3K ﹤0.01% 3348
2022
Q3
$87K Buy
13,052
+8,031
+160% +$53.5K ﹤0.01% 3454
2022
Q2
$32K Buy
5,021
+1,577
+46% +$10.1K ﹤0.01% 4064
2022
Q1
$16K Sell
3,444
-11,197
-76% -$52K ﹤0.01% 4518
2021
Q4
$73K Buy
14,641
+9,556
+188% +$47.6K ﹤0.01% 4127
2021
Q3
$61K Sell
5,085
-148,288
-97% -$1.78M ﹤0.01% 3893
2021
Q2
$3.24M Sell
153,373
-11,658
-7% -$247K ﹤0.01% 1750
2021
Q1
$4.63M Buy
165,031
+153,969
+1,392% +$4.32M ﹤0.01% 1379
2020
Q4
$288K Sell
11,062
-5,982
-35% -$156K ﹤0.01% 3007
2020
Q3
$634K Sell
17,044
-27,838
-62% -$1.04M ﹤0.01% 2122
2020
Q2
$2.3M Buy
44,882
+12,342
+38% +$633K ﹤0.01% 1538
2020
Q1
$1.03M Buy
32,540
+8,087
+33% +$255K ﹤0.01% 1793
2019
Q4
$1.46M Sell
24,453
-78,893
-76% -$4.71M ﹤0.01% 1907
2019
Q3
$3.79M Sell
103,346
-46,484
-31% -$1.7M ﹤0.01% 1211
2019
Q2
$6.97M Buy
149,830
+133,698
+829% +$6.22M 0.01% 970
2019
Q1
$647K Sell
16,132
-224,955
-93% -$9.02M ﹤0.01% 2303
2018
Q4
$11.1M Buy
241,087
+126,116
+110% +$5.8M 0.01% 660
2018
Q3
$5.1M Buy
114,971
+96,214
+513% +$4.27M ﹤0.01% 995
2018
Q2
$735K Sell
18,757
-614
-3% -$24.1K ﹤0.01% 2092
2018
Q1
$1.4M Sell
19,371
-46,381
-71% -$3.36M ﹤0.01% 1625
2017
Q4
$4.33M Buy
65,752
+37,200
+130% +$2.45M ﹤0.01% 1046
2017
Q3
$1.43M Sell
28,552
-28,803
-50% -$1.44M ﹤0.01% 1704
2017
Q2
$2.66M Buy
57,355
+35,949
+168% +$1.66M ﹤0.01% 1301
2017
Q1
$756K Buy
21,406
+10,876
+103% +$384K ﹤0.01% 2146
2016
Q4
$132K Sell
10,530
-3,992
-27% -$50K ﹤0.01% 3794
2016
Q3
$201K Buy
14,522
+1,900
+15% +$26.3K ﹤0.01% 2968
2016
Q2
$125K Sell
12,622
-11,926
-49% -$118K ﹤0.01% 3171
2016
Q1
$415K Sell
24,548
-16,188
-40% -$274K ﹤0.01% 2855
2015
Q4
$906K Buy
40,736
+19,363
+91% +$431K ﹤0.01% 1882
2015
Q3
$504K Sell
21,373
-670
-3% -$15.8K ﹤0.01% 2200
2015
Q2
$1.8M Buy
22,043
+8,600
+64% +$703K ﹤0.01% 1390
2015
Q1
$1.25M Sell
13,443
-4,053
-23% -$375K ﹤0.01% 1627
2014
Q4
$708K Sell
17,496
-1,844
-10% -$74.6K ﹤0.01% 2120
2014
Q3
$473K Buy
19,340
+202
+1% +$4.94K ﹤0.01% 2058
2014
Q2
$303K Buy
19,138
+384
+2% +$6.08K ﹤0.01% 2275
2014
Q1
$284K Sell
18,754
-555
-3% -$8.41K ﹤0.01% 2560
2013
Q4
$265K Buy
19,309
+8,709
+82% +$120K ﹤0.01% 2912
2013
Q3
$200K Buy
+10,600
New +$200K ﹤0.01% 2595